이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Fuan Pharmaceutical (Group) 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	n/a
경영진 평균 재임 기간	15yrs
이사회 평균 재임 기간	6.3yrs

최근 관리 업데이트

Recent updates

There's No Escaping Fuan Pharmaceutical (Group) Co., Ltd.'s (SZSE:300194) Muted Earnings

Aug 23

Does Fuan Pharmaceutical (Group) (SZSE:300194) Have A Healthy Balance Sheet?

Jun 07

Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit

May 02

Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price

Apr 03

CEO

Fuan Pharmaceutical (Group) 에는 CEO가 없거나 그에 대한 데이터가 없습니다.

리더십 팀

이름	위치	테뉴어	보상	소유권
Xue Song Yu	Deputy GM	15yrs	CN¥558.90k	0.011% CN¥ 601.3k
Jing Feng	Deputy General Manager	15yrs	CN¥561.90k	0.023% CN¥ 1.3m
Rong Chuan Hong	Deputy General Manager	15yrs	CN¥496.60k	0.016% CN¥ 880.4k
Yong Ping Sun	Deputy General Manager	4.1yrs	CN¥565.20k	0.025% CN¥ 1.4m
Tao Huang	Deputy GM & Director	11.8yrs	CN¥670.70k	0.74% CN¥ 41.7m
Xionghui Wu	Deputy General Manager	2.8yrs	CN¥561.50k	0.000080% CN¥ 4.5k
Qin Tang	Secretary of the Board of Directors & Director	15yrs	CN¥561.90k	0.024% CN¥ 1.4m

15.0yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: 300194 의 관리팀은 노련하고 경험 (평균 재직 기간 14.8 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Xue Song Yu	Deputy GM	15yrs	CN¥558.90k	0.011% CN¥ 601.3k
Tao Huang	Deputy GM & Director	11.8yrs	CN¥670.70k	0.74% CN¥ 41.7m
Qin Tang	Secretary of the Board of Directors & Director	15yrs	CN¥561.90k	0.024% CN¥ 1.4m
Lu Wang	Vice Chairman	2.8yrs	CN¥687.90k	데이터 없음
Tianxiang Wang	Chairman	15yrs	CN¥875.80k	24% CN¥ 1.4b
Zi Wei Guo	Supervisor	6.3yrs	CN¥197.50k	데이터 없음
Wei Wang	Director	6.3yrs	CN¥614.00k	데이터 없음
Wen Shuo Xiong	Independent Director	5.8yrs	CN¥60.00k	데이터 없음
Shu Zhu	Independent Director	5.8yrs	CN¥60.00k	데이터 없음
Geng Chen	Independent Director	2.8yrs	CN¥55.00k	데이터 없음
Yong Yang	Chairman of the Supervisory Board	2.2yrs	데이터 없음	데이터 없음

6.3yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 이사회: 300194 의 이사회는 경험(평균 재직 기간 6 년)으로 간주됩니다.

Fuan Pharmaceutical (Group) 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Fuan Pharmaceutical (Group) Co., Ltd., Annual General Meeting, May 24, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Fuan Pharmaceutical (Group) Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Investor sentiment improves as stock rises 27%

Second quarter 2024 earnings released: EPS: CN¥0.08 (vs CN¥0.07 in 2Q 2023)

There's No Escaping Fuan Pharmaceutical (Group) Co., Ltd.'s (SZSE:300194) Muted Earnings

Fuan Pharmaceutical (Group) Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Does Fuan Pharmaceutical (Group) (SZSE:300194) Have A Healthy Balance Sheet?

Fuan Pharmaceutical (Group) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024

Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit

Fuan Pharmaceutical (Group) Co., Ltd. Proposes Final Cash Dividend for 2023

Fuan Pharmaceutical (Group) Co., Ltd., Annual General Meeting, May 24, 2024

First quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.07 in 1Q 2023)

Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price

Fuan Pharmaceutical (Group) Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Investor sentiment deteriorates as stock falls 17%

Fuan Pharmaceutical (Group) Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.04 in 3Q 2022)

Investor sentiment improves as stock rises 19%

Second quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.04 in 2Q 2022)

Fuan Pharmaceutical (Group) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 12 May 2023

First quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.03 in 1Q 2022)

Now 22% undervalued

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.06 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 2Q 2021)

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.05 in 2Q 2020)

Fuan Pharmaceutical (Group) Co., Ltd. Announces Implementation of Profit Distribution Plan for A Shares for the Year 2020, Payable on 14 May 2021

First quarter 2021 earnings released: EPS CN¥0.05 (vs CN¥0.06 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.18 (vs CN¥0.25 in FY 2019)

Fuan Pharmaceutical (Group) Co., Ltd. to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: CN¥4.18

New 90-day low: CN¥4.74

Investor sentiment deteriorated over the past week

New 90-day low: CN¥5.42

New 90-day high - CN¥6.57

Fuan Pharmaceutical (Group) Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥6.27

CEO

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령